We are pleased to announce Mr. Jeffrey Stein as the newest member of CRIO’s Board of Directors!
Jeff Stein currently serves as the CEO and President of ALSA Research, which has been an early adopter of cloud-based technologies that are now standard practices across the clinical research industry. After beginning his career on Wall Street with Salomon Brothers, Jeff opened the firm’s London based MBS group. Shortly after, Jeff acquired a controlling interest in Healthcare Properties (HCP) where he served as managing partner. More recently, Jeff has taken on multiple leadership roles at several startup companies, including Matrix Medical Network and XTG LLC. Jeff’s expertise in healthcare technology will play a vital role in advancing our organization.
We’ve known Jeff for years, and couldn’t think of a better person to be on our Board of Directors. Jeff is forward-thinking, with a broad knowledge of the industry and a sophisticated understanding of business.
-Raymond Nomizu, CEO
Raymond and I have shared a vision for the development and use of eSource in clinical trials since before a single line of code was ever written. I became an investor in CRIO and a beta site user with the very first release. I am delighted to join this board and am excited about the future of the company.
-Jeff Stein
We are grateful for our entire Board of Directors for their commitment to our company, partners and clients. Please join us in welcoming Jeff to the CRIO family!
